TGFB1 and renal cell carcinoma: To determine whether TGF-β treatment mediates inhibition of PAX2 expression directly or indirectly via regulation of the PAX2 promoter, we investigated whether TGF-β1 treatment could suppress transiently transfected human PAX2 promoter constructs in kidney and RCC cell lines.